Delivery Order SPE2DB20D3104-SPE2DB24FV5L3
- Not listed
- This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,504.30 delivery order is for 4,558,371,656 units of Atomoxetine HCL 40 mg capsules. The award is part of a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Atomoxetine HCL 60 mg capsules. The contract has a ceiling value of $1,069.76 and a performance period ending on December 12, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Federal Contract Award SPE2DX15D1053|SPE2DX23F6NET was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,726.32 Firm Fixed Price Delivery Order is for the supply of 4560942254 - Atomoxetine HCL 40 MG Capsule 30S. This contract is not designated with a set-aside requirement. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Atomoxetine HCL 40 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 30, 2022 with a ceiling value of $2,114.66. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of March 31, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,244.48 firm fixed-price delivery order is for the supply of Atomoxetine HCL 25 mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $1,690.44 delivery order for the supply of 4557030315 - Atomoxetine HCL 40 MG Capsules. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,561,888,754 units of Atomoxetine HCL 18 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The Delivery Order contract, valued at $4,381.89, has a firm fixed price and an ultimate completion date of August 22, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $1,404.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of Atomoxetine HCL 25 mg capsules. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Atomoxetine HCL 18 mg capsules, with a ceiling value of $2,205.42 and a performance period extending to May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB24FV5L3Delivery Order
This federal contract award, with ID SPE2DB20D3104 and SPE2DB24FV5L3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,858.04 fixed-price delivery order is for the supply of 4563940986 - Atomoxetine HCL 40 mg capsules, with a completion date of March 13, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/12/24 |